Clinical Trial Update: Dose Finding Study to Assess Safety and Efficacy of Stem Cells in Liver Cirrhosis [Phase 2]

View source ↗

Summary

A Phase 2 dose-finding study assessing the safety and efficacy of stem cell therapy in alcoholic liver cirrhosis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alcoholic Liver Cirrhosis

Drugs mentioned

• Stem cells (mesenchymal stem cells)

Snippet

Sponsor: Stempeutics Research Pvt Ltd | Conditions: Alcoholic Liver Cirrhosis | Phase 2 | Status: COMPLETED